Medicare formularies were inconsistent in increasing restrictiveness to drugs that received FDA black box warnings for death and/or cardiovascular risk with safer available drug alternatives.
Daniel L. Shaw, BA
Advertisement
Articles by Daniel L. Shaw, BA
Advertisement
Latest Updated Articles
- Association Between FDA Black Box Warnings and Medicare Formulary Coverage Changes
Published: September 29th 2017 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Digital, Blood-Based Innovations Transform Alzheimer Disease Detection: Ken Cohen, MD, FACP
2
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
3
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
4
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
5
